OP 1.7 – 00194 Potent latency reversal enables in-depth transcriptomic analysis of the translation-competent HIV-1 reservoir

OP 1.7 – 00194 Potent latency reversal enables in-depth transcriptomic analysis of the translation-competent HIV-1 reservoir

Bibliographic Details
Main Authors:	M. Pardons, B. Cole, L. Lambrechts, S. Rutsaert, Y. Noppe, J. Vega, E. Nijs, E. Van Gulck, D. Boden, L. Vandekerckhove
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664022000401

Similar Items

Potent latency reversal by Tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoir
by: Marion Pardons, et al.
Published: (2023-12-01)

PP 1.23 – 00130 Long-read sequencing assay allows accurate characterization of the HIV-1 reservoir
by: L. Lambrechts, et al.
Published: (2022-12-01)

OP 3.8 – 00066 Characterization of the HIV-1 viral reservoir in subtype B early treated individuals
by: T. Struyve, et al.
Published: (2022-12-01)

PP 3.9 – 00146 Impact of time on antiretroviral therapy on the proviral reservoir in people living with HIV
by: S. Rutsaert, et al.
Published: (2022-12-01)

In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of plasma viremia
by: Basiel Cole, et al.
Published: (2021-06-01)

Emerging PCR-Based Techniques to Study HIV-1 Reservoir Persistence
by: Laurens Lambrechts, et al.
Published: (2020-01-01)

OP 8.2 – 00033 Interleukin-2 administration is a potent latency reversal agent in people with treated HIV infection
by: M. Freeman, et al.
Published: (2022-12-01)

OP 1.5 – 00046 P400/Tip60 chromatin remodeling complex in HIV transcription and latency establishment
by: L. Mori, et al.
Published: (2022-12-01)

P1 Contribution of lncRNAs in the establishment of HIV latency in central memory CD4 T Cells
by: Wim Trypsteen, et al.
Published: (2017-09-01)

In-depth transcription profile comparison of multiple primary cell HIV latency models
by: S. Moron-Lopez, et al.
Published: (2019-07-01)

P1 Protein expression from unintegrated HIV-1 DNA introduces bias in primary in vitro latency models
by: Pawel Bonczkowski, et al.
Published: (2016-09-01)

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
by: Catherine A. Lewis, et al.
Published: (2023-07-01)

OP 2.8 – 00193 Enhancing PKC Modulator HIV Latency Reversing Agents
by: M. Marsden, et al.
Published: (2022-12-01)

Estrogen potently blocks HIV re-emergence from latency and points to gender-specific differences in HIV reservoirs and novel cure strategies
by: J. Karn, et al.
Published: (2015-12-01)

SMAC mimetics are potent latency reversal agents with single agent and combination activity ex vivo
by: R.M. Dunham, et al.
Published: (2017-12-01)

Latency-Reversing Agents Induce Differential Responses in Distinct Memory CD4 T Cell Subsets in Individuals on Antiretroviral Therapy
by: Marion Pardons, et al.
Published: (2019-11-01)

HIV-1 latency in actively dividing human T cell lines
by: Berkhout Ben, et al.
Published: (2008-04-01)

Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
by: Alexander O. Pasternak, et al.
Published: (2023-04-01)

Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1: a Phase IIa randomised controlled study
by: Sofie Rutsaert, et al.
Published: (2019-01-01)

Effect of temperature on dielectric properties and penetration depth of oil palm shell (OPS) and OPS char synthesized by microwave pyrolysis of OPS
by: Tripathi, M., et al.
Published: (2015)

HIV-1 Transcription and Latency in the Spotlight
by: Iván D’Orso
Published: (2024-02-01)

Latency: the hidden HIV-1 challenge
by: Marcello Alessandro
Published: (2006-01-01)

HIV-1 Latency in Monocytes/Macrophages
by: Amit Kumar, et al.
Published: (2014-04-01)

The OPS-1 Manual
by: Greenberger, Martin
Published: (2023)

Suppression of the HIV-1 reservoir with a potent Tat inhibitor
by: S. Valente, et al.
Published: (2015-12-01)

HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies
by: Sushant Khanal, et al.
Published: (2021-02-01)

Corrigendum: Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
by: Alexander O. Pasternak, et al.
Published: (2023-05-01)

Epigenetic regulation of HIV-1 latency by cytosine methylation.
by: Steven E Kauder, et al.
Published: (2009-06-01)

OP8: Amniotic Membrane: A Potent Biological Dressing in Wound Management
by: Martin Hladík, et al.
Published: (2022-01-01)

Elimination of HIV-1-Infected Primary T Cell Reservoirs in an In Vitro Model of Latency.
by: Stephen A Rawlings, et al.
Published: (2015-01-01)

Hormonal control of HIV-1 latency by estrogen imparts gender-specific restrictions on the latent reservoir
by: J. Karn, et al.
Published: (2019-07-01)

O2 Cross-validation of HIV DNA assays to quantify different HIV-1 subtypes by ddPCR
by: S. Rutsaert, et al.
Published: (2016-09-01)

The cell biology of HIV-1 latency and rebound
by: Uri Mbonye, et al.
Published: (2024-04-01)

Differential proviral latency of the HIV-1 subtypes B and AE
by: Jeeninga Rienk E, et al.
Published: (2011-10-01)

CL572, a potent agonist of Toll-like receptor 2/7, as a novel latency-reversing agent
by: A. Macedo, et al.
Published: (2015-12-01)

HIV persistence in lymph nodes from virally suppressed individuals: residual production VS latency
by: M. Pardons, et al.
Published: (2017-12-01)

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.
by: Ole S Søgaard, et al.
Published: (2015-09-01)

Can immunotherapy be useful as a “functional cure” for infection with Human Immunodeficiency Virus-1?
by: Vanham Guido, et al.
Published: (2012-09-01)

Women undergoing reproductive aging show increased reservoir sizes associated with removal of hormonal control of HIV-1 latency by oestrogen
by: C. Dobrowolski, et al.
Published: (2019-12-01)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019-12-01)